.

Subscribe for Complete Access

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Covington
Mallinckrodt
Boehringer Ingelheim
Novartis
Julphar
Fuji
Dow
Merck
Citi

Generated: July 28, 2017

DrugPatentWatch Database Preview

Nelfinavir mesylate - Generic Drug Details

« Back to Dashboard

What are the generic sources for nelfinavir mesylate and what is the scope of nelfinavir mesylate freedom to operate?

Nelfinavir mesylate
is the generic ingredient in one branded drug marketed by Agouron Pharms and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for nelfinavir mesylate. Four suppliers are listed for this compound.

Summary for Generic Name: nelfinavir mesylate

Tradenames:1
Patents:0
Applicants:1
NDAs:3
Drug Master File Entries: see list3
Suppliers / Packagers: see list4
Bulk Api Vendors: see list33
Clinical Trials: see list634
Patent Applications: see list3,401
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:nelfinavir mesylate at DailyMed

Pharmacology for Ingredient: nelfinavir mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Agouron Pharms
VIRACEPT
nelfinavir mesylate
TABLET;ORAL021503-001Apr 30, 2003RXYesYes► Subscribe► Subscribe► Subscribe
Agouron Pharms
VIRACEPT
nelfinavir mesylate
TABLET;ORAL020779-001Mar 14, 1997RXYesYes► Subscribe► Subscribe► Subscribe
Agouron Pharms
VIRACEPT
nelfinavir mesylate
POWDER;ORAL020778-001Mar 14, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: nelfinavir mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Agouron Pharms
VIRACEPT
nelfinavir mesylate
POWDER;ORAL020778-001Mar 14, 1997► Subscribe► Subscribe
Agouron Pharms
VIRACEPT
nelfinavir mesylate
TABLET;ORAL021503-001Apr 30, 2003► Subscribe► Subscribe
Agouron Pharms
VIRACEPT
nelfinavir mesylate
TABLET;ORAL021503-001Apr 30, 2003► Subscribe► Subscribe
Agouron Pharms
VIRACEPT
nelfinavir mesylate
TABLET;ORAL020779-001Mar 14, 1997► Subscribe► Subscribe
Agouron Pharms
VIRACEPT
nelfinavir mesylate
POWDER;ORAL020778-001Mar 14, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Mallinckrodt
Boehringer Ingelheim
US Department of Justice
Deloitte
Chinese Patent Office
Citi
UBS
Novartis
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot